Triodos Investment Management’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-62,750
| Closed | -$4.74M | – | 51 |
|
|
2026
Q1 | $4.74M | Hold |
62,750
| – | – | 0.36% | 40 |
|
|
2025
Q4 | $4.68M | Hold |
62,750
| – | – | 0.34% | 42 |
|
|
2025
Q3 | $4.23M | Buy |
62,750
+1,750
| +3% | +$116K | 0.31% | 41 |
|
|
2025
Q2 | $3.97M | Buy |
61,000
+8,500
| +16% | +$509K | 0.3% | 41 |
|
|
2025
Q1 | $3.22M | Buy |
52,500
+10,500
| +25% | +$696K | 0.26% | 42 |
|
|
2024
Q4 | $3.03M | Buy |
42,000
+6,750
| +19% | +$527K | 0.24% | 41 |
|
|
2024
Q3 | $2.87M | Buy |
35,250
+7,750
| +28% | +$620K | 0.23% | 41 |
|
|
2024
Q2 | $2.04M | Buy |
27,500
+2,500
| +10% | +$187K | 0.18% | 40 |
|
|
2024
Q1 | $1.95M | Buy |
25,000
+2,000
| +9% | +$149K | 0.18% | 39 |
|
|
2023
Q4 | $1.64M | Buy |
23,000
+1,000
| +5% | +$69.6K | 0.16% | 39 |
|
|
2023
Q3 | $1.53M | Buy |
22,000
+2,500
| +13% | +$189K | 0.16% | 40 |
|
|
2023
Q2 | $1.58M | Buy |
19,500
+1,000
| +5% | +$81.7K | 0.16% | 37 |
|
|
2023
Q1 | $1.49M | Buy |
18,500
+1,500
| +9% | +$121K | 0.17% | 39 |
|
|
2022
Q4 | $1.27M | Hold |
17,000
| – | – | 0.17% | 36 |
|
|
2022
Q3 | $1.1M | Buy |
17,000
+1,500
| +10% | +$104K | 0.16% | 39 |
|
|
2022
Q2 | $1.07M | Buy |
+15,500
| New | +$1.15M | 0.15% | 42 |
|
Other funds holding HOLX
Triodos Investment Management's HOLX Position: Q2 2026 in Review
Triodos Investment Management sold out of Hologic (HOLX) in Q2 2026, closing a stake of 62,750 shares — an estimated $4.74M sold.
Triodos Investment Management first reported a position in HOLX in Q2 2022 and held it in 16 quarters. The position peaked at $4.74M in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- Triodos Investment Management reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- Triodos Investment Management sold 62,750 Hologic shares in Q2 2026, an estimated $4.74M.
- Triodos Investment Management first reported a position in Hologic in Q2 2022 and held it in 16 quarters.
- Triodos Investment Management's Hologic position peaked at $4.74M in Q1 2026.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on Triodos Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.